SLC25A16 antibody
Quick Overview for SLC25A16 antibody (ABIN207568)
Target
See all SLC25A16 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Synthetic peptide corresponding to middle residues of human GDC (Grave's disease carrier protein)
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human SLC25A16.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- SLC25A16 (Solute Carrier Family 25 (Mitochondrial Carrier, Graves Disease Autoantigen), Member 16 (SLC25A16))
-
Alternative Name
- SLC25A16 / GDA / Graves
-
Background
-
Name/Gene ID: SLC25A16
Subfamily: Mitochondrial carrier
Family: Transporter
Synonyms: SLC25A16, D10S105E, Graves disease autoantigen, Graves', HML7, HGT.1, Graves, ML7, GDC, Graves disease carrier protein, Graves' disease autoantigen -
Gene ID
- 8034
-
UniProt
- P16260
Target
-